Skip Intro

Dynavax

Dynavax is a pre-commercial stage biotechnology company developing products to help the immune system resist disease. In 2007, Deerfield partnered with Dynavax to provide a customized $30 million milestone driven financing to accelerate its toll like receptor (TLR) based allergy program into more indications.